# Clinical Trial of TJ0113 Capsules in the Treatment of Patients With Depressive Disorder

> **NCT07018245** · PHASE2 · RECRUITING · sponsor: **Hangzhou PhecdaMed Co., Ltd.** · enrollment: 150 (estimated)

## Conditions studied

- Depression

## Interventions

- **DRUG:** TJ0113
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07018245
- **Lead sponsor:** Hangzhou PhecdaMed Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-09
- **Primary completion:** 2026-05-25
- **Final completion:** 2026-09-01
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07018245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07018245, "Clinical Trial of TJ0113 Capsules in the Treatment of Patients With Depressive Disorder". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT07018245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*